Effects of SecDF on the antimicrobial functions of cathelicidins against Staphylococcus aureus

Veterinary Microbiology

Volumn 200, Issue , 2017, Pages 52-58

  Blodkamp, Stefanie ^a,b   Kadlec, Kristina ^b   Gutsmann, Thomas ^c   Quiblier, Chantal ^d   Naim, Hassan Y ^a   Schwarz, Stefan ^b   von Köckritz Blickwede, Maren ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antimicrobial peptides; Efflux pump inhibitors; Minimal inhibitory concentration (MIC); RND efflux pumps

Indexed keywords

BMAP 28 PROTEIN; CAP18 PROTEIN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GENOMIC DNA; MOUSE CRAMP PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; SECDF PROTEIN; UNCLASSIFIED DRUG; 1-(1-NAPHTHYLMETHYL)PIPERAZINE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; BMAP-27; BMAP-28; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CARRIER PROTEIN; ENZYME INHIBITOR; MEMBRANE PROTEIN; PIPERAZINE DERIVATIVE; PROTEIN; SECD PROTEIN, BACTERIA; SECF PROTEIN, BACTERIA;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; DNA EXTRACTION; ENZYME INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; ANIMAL; BOVINE; DISEASE PREDISPOSITION; DRUG EFFECTS; GENETICS; HUMAN; LEPORIDAE; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOUSE; STAPHYLOCOCCAL INFECTIONS; VETERINARY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; CATHELICIDINS; CATTLE; DISEASE SUSCEPTIBILITY; ENZYME INHIBITORS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; PROTEINS; RABBITS; STAPHYLOCOCCAL INFECTIONS;

EID: 84962446599     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2016.03.021     Document Type: Article

References (40)

1. Alnaseri, H., Arsic, B., Schneider, J., Kaiser, J.C., Scinocca, Z.C., Heinrichs, D.E., McGavin, M.J., Inducible expression of a resistance-nodulation-division-type efflux pump in Staphylococcus aureus provides resistance to linoleic and arachidonic acids. J. Bacteriol. 197 (2015), 1893–1905.
2. Anderson, R.C., Yu, P.L., Factors affecting the antimicrobial activity of ovine-derived cathelicidins against E. coli 0157:H7. Int. J. Antimicrob. Agents 25 (2005), 205–210.
3. Andrä, J., Hammer, M.U., Grötzinger, J., Jakovkin, I., Lindner, B., Vollmer, E., Fedders, H., Leippe, M., Gutsmann, T., Significance of the cyclic structure and of arginine residues for the antibacterial activity of arenicin-1 and its interaction with phospholipid and lipopolysaccharide model membranes. Biol. Chem. 390 (2009), 337–349.
4. Bayer, A.S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R.A., Firth, N., Brown, M.H., Koo, S.P., Yeaman, M.R., In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 68 (2000), 3548–3553.
5. Bengoechea, J.A., Skurnik, M., Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol. Microbiol. 37 (2000), 67–80.
6. Blodkamp, S., Kadlec, K., Gutsmann, T., Naim, H.Y., von Köckritz-Blickwede, M., Schwarz, S., In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus. Vet. Microbiol., 2015, 10.1016/j.vetmic.2015.09.018 (in press).
7. Clinical and Laboratory Standards Institute, Generation, presentation, and application of antimicrobial susceptibility test data for bacteria of animal origin; a report. CLSI Document VET05-R, 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. CLSI Document VET01-A4, fourth edition, 2013, Clinical and Laboratory Standards Institute, Wayne, PA.
9. Charpentier, E., Anton, A.I., Barry, P., Alfonso, B., Fang, Y., Novick, R.P., Novel cassette-based shuttle vector system for Gram-positive bacteria. Appl. Environ. Microbiol. 70 (2004), 6076–6085.
10. + uptake protein, TrkA, is required for serum, protamine, and polymyxin B resistance in Vibrio vulnificus. Infect. Immun. 72 (2004), 629–636.
11. Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., Courvalin, P., AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52 (2008), 557–562.
12. De Smet, K., Contreras, R., Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett. 27 (2005), 1337–1347.
13. Duthie, E.S., Lorenz, L.L., Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6 (1952), 95–107.
14. Elkins, C.A., Mullis, L.B., Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J. Bacteriol. 188 (2006), 1191–1195.
15. Ender, M., Berger-Bächi, B., McCallum, N., Variability in SCCmecN1 spreading among injection drug users in Zürich, Switzerland. BMC Microbiol. 7 (2007), 62–72.
16. Feßler, A., Scott, C., Kadlec, K., Ehricht, R., Monecke, S., Schwarz, S., Characterization of methicillin-resistant Staphylococcus aureus ST398 from cases of bovine mastitis. J. Antimicrob. Chemother. 65 (2010), 619–625.
17. Frempong-Manso, E., Raygada, J.L., DeMarco, C.E., Seo, S.M., Kaatz, G.W., Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus. Int. J. Antimicrob. Agents 33 (2009), 360–363.
18. Hancock, R.E., Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1 (2001), 156–164.
19. Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., Tarkowski, A., Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172 (2004), 1169–1176.
20. Kadlec, K., Kehrenberg, C., Schwarz, S., Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J. Antimicrob. Chemother. 59 (2007), 191–196.
21. Kupferwasser, L.I., Skurray, R.A., Brown, M.H., Firth, N., Yeaman, M.R., Bayer, A.S., Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob. Agents Chemother. 43 (1999), 2395–2399.
22. Lycklama a Nijeholt, J.A., Driessen, A.J.M., The bacterial Sec-translocase: structure and mechanism. Philos. Trans. R. Soc. B Biol. Sci. 367 (2012), 1016–1028.
23. Mazzotta, A.S., Montville, T.J., Nisin induces changes in membrane fatty acid composition of Listeria monocytogenes nisin-resistant strains at 10 degrees C and 30 degrees C. J. Appl. Microbiol. 82 (1997), 32–38.
24. Milano, A., Pasca, M.R., Provvedi, R., Lucarelli, A.P., Manina, G., Luisa de Jesus Lopes Ribeiro, A., Manganelli, R., Riccardi, G., Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system. Tuberculosis 89 (2009), 84–90.
25. Mishra, N.N., Liu, G.Y., Yeaman, M.R., Nast, C.C., Proctor, R.A., McKinnell, J., Bayer, A.S., Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55 (2011), 526–531.
26. Nawrocki, K.L., Crispell, E.K., McBride, S.M., Antimicrobial peptide resistance mechanisms in Gram-positive bacteria. Antibiotics 29 (2012), 997–1003.
27. Parra-Lopez, C., Baer, M.T., Groisman, E.A., Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J. 12 (1993), 4053–4062.
28. Parra-Lopez, C., Lin, R., Aspedon, A., Groisman, E.A., A Salmonella protein that is required for resistance to antimicrobial peptides and transport of potassium. EMBO J. 13 (1994), 3964–3972.
29. Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W.F., Jung, G., Tarkowski, A., van Kessel, K.P., van Strijp, J.A., Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193 (2001), 1067–1076.
30. Qi, W., Ender, M., Brien, F.O., Imhof, A., Ruef, C., Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Zürich, Switzerland (2003): prevalence of type IV SCCmec and a new SCCmec element associated with isolates from intrevenous drug users. J. Clin. Microbiol. 43 (2005), 5164–5170.
31. Quiblier, C., Zinkernagel, A.S., Schuepbach, R.A., Berger-Bächi, B., Senn, M.M., Contribution of SecDF to Staphylococcus aureus resistance and expression of virulence factors. BMC Microbiol. 11 (2011), 72–84.
32. Quiblier, C., Seidl, K., Roschitzki, B., Zinkernagel, A.S., Berger-Bächi, B., Senn, M.M., Secretome analysis defines the major role of SecDF in Staphylococcus aureus virulence. PLoS One 8 (2013), 1–12, 10.1371/journal.pone.0063513.
33. Shafer, W.M., Qu, X., Waring, A.J., Lehrer, R.I., Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 1829–1833.
34. Sun, J., Deng, Z., Yan, A., Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem. Biophys. Res. Commun. 453 (2014), 254–267.
35. Tseng, T.T., Gratwick, K.S., Kollman, J., Park, D., Nies, D.H., Goffeau, A., Saier, M.H. Jr., The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1 (1999), 107–125.
36. Tzeng, Y., Ambrose, K.D., Zughaier, S., Zhou, X., Miller, Y.K., Shafer, W.M., Stephens, D.S., Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187 (2005), 5387–5396.
37. Verheul, A., Russell, N.J., Hof, R.V.T., Rombouts, F.M., Abee, T., Rombouts, F.M., Abee, T., Modifications of membrane phospholipid composition in nisin-resistant Listeria modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol. 63 (1997), 3451–3457.
38. Wendlandt, S., Kadlec, K., Feßler, A.T., Monecke, S., Ehricht, R., van de Giessen, A.W., Hengeveld, P.D., Huijsdens, X., Schwarz, S., van Duijkeren, E., Resistance phenotypes and genotypes of methicillin-resistant Staphylococcus aureus isolates from broiler chickens at slaughter and abattoir workers. J. Antimicrob. Chemother. 68 (2013), 2458–2463.
39. Wieckowska-Szakiel, M., Sadowska, B., Rózalska, B., Staphylokinase production by clinical Staphylococcus aureus strains. Pol. J. Microbiol. 56 (2007), 97–102.
40. Zähner, D., Zhou, X., Chancey, S.T., Pohl, J., Shafer, W.M., Stephens, D.S., Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 54 (2010), 3516–3519.